GeneBio Systems
Phospho-FOXO1/3 (Ser322/S325) Polyclonal Antibody
Phospho-FOXO1/3 (Ser322/S325) Polyclonal Antibody
SKU:E-AB-21016
Couldn't load pickup availability
Size: 200μL
Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.
Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.
Exp date: 12 months
Category ID_II: Primary Antibodies
Category ID_III: Acetyl/Phospho/Methyl Antibodies
Abbreviation: FoxO1/3 (phospho Ser322/S325)
Target Synonym: FOXO1;FKHR;FOXO1A;Forkhead box protein O1;Forkhead box protein O1A;Forkhead in rhabdomyosarcoma;FOXO3;FKHRL1;FOXO3A;Forkhead box protein O3;AF6q21 protein;Forkhead in rhabdomyosarcoma-like 1
Research Areas: Cancer;Epigenetics and Nuclear Signaling;Metabolism;Neuroscience;Signal Transduction
Conjugation: Unconjugated
Host: Rabbit
Species reactivity: Human;Mouse;Rat
Application: WB;IHC-p
Isotype: IgG
Clonality: Polyclonal
Clone NO.:
UNIProt ID: Q12778,O43524
Accession:
Background: FOXO1 (Forkhead Box O1) is a Protein Coding gene. Diseases associated with FOXO1 include Rhabdomyosarcoma 2, Alveolar and Rhabdomyosarcoma. Among its related pathways are Constitutive Signaling by AKT1 E17K in Cancer and Common Cytokine Receptor Gamma-Chain Family Signaling Pathways. GO annotations related to this gene include transcription factor activity, sequence-specific DNA binding and chromatin binding. An important paralog of this gene is FOXO3. FOXO3 (Forkhead Box O3) is a Protein Coding gene. Diseases associated with FOXO3 include Rhabdomyosarcoma and Lung Cancer. Among its related pathways are Development IGF-1 receptor signaling and Constitutive Signaling by AKT1 E17K in Cancer. GO annotations related to this gene include transcription factor activity, sequence-specific DNA binding and protein kinase binding. An important paralog of this gene is FOXO1.
Concentration: 1 mg/mL
Immunogen: Synthesized peptide derived from human FoxO1/3 around the phosphorylation site of Ser322/S325
Buffer: PBS with 0.02% sodium azide, 0.5% protective protein and 50% glycerol, pH7.4
Purification method: Affinity purification
Dilution: WB 1:500-1:2000;IHC 1:100-1:300
Calculated MW: 70kDa
ObservedMW: 97kDa
